Search results
Results from the WOW.Com Content Network
Cannabidiol dimethyl ether (CBDD) is a trace component of cannabis [citation needed] which can also be made synthetically. It is a potent and selective inhibitor of the enzyme 15-lipoxygenase and inhibits oxygenation of linoleic acid , a process involved in the development of atherosclerosis .
It is thought to act as a CB 1 receptor agonist, in a similar manner to other cannabinoid derivatives. [5] [6] While DMHP itself has been subject to relatively little study since the characterization of the cannabinoid receptors, the structural isomer 1,2-dimethylheptyl-Δ 8-THC has been shown to be a highly potent cannabinoid agonist, and the activity of its enantiomers has been studied ...
HU-210, the (–) enantiomer, is an ultrapotent cannabinoid, while its (+) enantiomer HU-211 is not a cannabinoid, but an NMDA antagonist with neuroprotective effects. [ 10 ] [ 11 ] HU-210 has an oral LD 50 of 5,000 mg/kg in rats and 14,200 mg/kg in rabbits, [ 12 ] and an LD LO (lowest lethal dose) of 143 mg/kg in humans. [ 12 ]
The earliest systematic studies of physiological effects of cannabis-derived chemical were conducted in the 1920's (see Fig. The number of publications about marijuana/cannabis). The level or research activity in this area remained relatively low and constant until 1966, when a 10-fold increase in publication activity occurred within 10 years.
Dimethyl ether (DME; also known as methoxymethane) is the organic compound with the formula CH 3 OCH 3, (sometimes ambiguously simplified to C 2 H 6 O as it is an isomer of ethanol). The simplest ether , it is a colorless gas that is a useful precursor to other organic compounds and an aerosol propellant that is currently being demonstrated for ...
Cannabis as illustrated in Köhler's Book of Medicinal Plants, 1897. Overall, research into the health effects of medical cannabis has been of low quality and it is not clear whether it is a useful treatment for any condition, or whether harms outweigh any benefit. [18] There is no consistent evidence that it helps with chronic pain and muscle ...
A dried cannabis flower. The short-term effects of cannabis are caused by many chemical compounds in the cannabis plant, including 113 [clarification needed] different cannabinoids, such as tetrahydrocannabinol, and 120 terpenes, [1] which allow its drug to have various psychological and physiological effects on the human body.
Synthetic cannabinoids were made for cannabinoid research focusing on tetrahydrocannabinol (THC), cannabinoid receptors, and the endocannabinoids that activate them in the body. Synthetic cannabinoids were needed partly due to legal restrictions on natural cannabinoids, which make them difficult to obtain for research.